Data / Drug companies / Pseudoephedrine hydrochloride
Pseudoephedrine hydrochloride: 23 companies and 39 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Pseudoephedrine hydrochloride is listed in the FDA National Drug Code Directory by 23 companies, with 39 products in commercial distribution. 30 of the products (76.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated, extended release; tablet, film coated; tablet, and the newest product started marketing on January 30, 2026.
The request: Get every company that lists pseudoephedrine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 23
- Products
- 39
- Generic (ANDA) products
- 30 (76.9%)
- Application numbers
- 4
- Routes
- Oral
- Brand names
- Nasal Decongestant, 12 Hour Nasal Decongestant, Sudafed Sinus Congestion 12 Hour, Leader 12 Hour Nasal Decongestant, Sinus and Nasal Decongestant, Zephrex D, Good Neighbor Pharmacy Nasal Decongestant, Nasal Decongestant D
- openFDA record search
- api.fda.gov
Companies that list pseudoephedrine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Major Pharmaceuticals | 4 | tablet; tablet, film coated | Over the counter monograph drugs | June 7, 2024 |
| A-S Medication Solutions | 3 | tablet, film coated, extended release; tablet | Generic drugs (ANDA) | August 26, 2019 |
| Cardinal Health 110, LLC. DBA Leader | 3 | tablet, film coated, extended release; tablet | Generic drugs (ANDA) | May 16, 2024 |
| Kenvue Brands LLC | 3 | solution; tablet, film coated, extended release | Over the counter monograph drugs | July 31, 2021 |
| Walgreen Company | 3 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | January 30, 2026 |
| CVS Woonsocket Prescription Center, Incorporated | 2 | tablet, film coated, extended release; tablet, film coated | Generic drugs (ANDA) | January 20, 2026 |
| Kroger Company | 2 | tablet, film coated; tablet | Over the counter monograph drugs | February 19, 2021 |
| L. Perrigo Company | 2 | capsule, gelatin coated; tablet, film coated, extended release | Over the counter monograph drugs | November 4, 2016 |
| Ohm Laboratories Inc. | 2 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | April 28, 2006 |
| Publix Super Markets Inc | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | April 28, 2006 |
| Amerisource Bergen | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | August 12, 1999 |
| Aurohealth LLC | 1 | tablet, extended release | Generic drugs (ANDA) | December 29, 2025 |
| CVS Pharmacy | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | December 1, 1999 |
| Chain Drug Marketing Association | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | April 28, 2006 |
| H E B | 1 | tablet, extended release | Generic drugs (ANDA) | May 15, 2019 |
| HyVee Inc | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | September 11, 2000 |
| Meijer Distribution Inc | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | November 28, 2018 |
| Sam's West Inc | 1 | tablet, film coated | Generic drugs (ANDA) | February 7, 2012 |
| Sportpharm LLC | 1 | tablet, film coated | Generic drugs (ANDA) | April 28, 2006 |
| Strategic Sourcing Services LLC | 1 | tablet, film coated | Generic drugs (ANDA) | August 10, 2023 |
| Topco Associates LLC | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | April 25, 2000 |
| United Natural Foods, Inc. DBA Unfi | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | August 10, 2004 |
| Wal-Mart Stores Inc | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | June 24, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated, extended release | 17 | 43.6% |
| Tablet, film coated | 10 | 25.6% |
| Tablet | 6 | 15.4% |
| Tablet, extended release | 4 | 10.3% |
| Capsule, gelatin coated | 1 | 2.6% |
| Solution | 1 | 2.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 30 | 76.9% |
| Over the counter monograph drugs | 9 | 23.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| alpha-Adrenergic Agonist | 39 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.